J Korean Soc Aesthetic Plast Surg.  2003 Mar;9(1):17-21.

The Evaluation of the Effect of Aminophylline Injection to Subcutaneous Fat Reduction

• Kim HK
• Kim YW
• Kim HJ

Abstract

The obesity induce not only physical problem, but psychological and emotional problem. The focus of body contour procedures is the body's unequal distribution of fat. Aminophylline is a 2-adrenaline agonist, an adenosine inhibitor, and a phosphodiesterase inhibitor. It activates c-AMP, and facilitates lipolysis. Forty rats were used to study the effect of aminophylline subcutaneous injection, and divided in four groups, In the control group(n=10), saline was injected to subcutaneous fat of the abdomen. In the experimental group, aminophylline 50 mg/kg(n=10), 100 mg/kg(n=10) and 200 mg/kg(n=10) were injected. The injection was done daily for three weeks. The four groups were measured by weight, abdomen circumference, biochemistry, and histopathological test. There were no difference among the four groups. In conclusion, aminophylline subcutaneous injection is not effective in the reduction of regional and systemic fat.

Keyword

Aminophylline; Subcutaneous injection; Lipolysis

MeSH Terms

Abdomen
Adenosine
Aminophylline*
Animals
Biochemistry
Injections, Subcutaneous
Lipolysis
Obesity
Rats
Subcutaneous Fat*
Adenosine
Aminophylline